in

Having Asthma, Allergies Raises Your Heart Risks

If you have asthma or allergies, you may be more likely to develop heart disease, and some medications may increase or lower that risk, a new review of clinical trials and lab research shows.

“Many people think of asthma as a disease of the lungs, but there’s an important link between asthma and cardiovascular diseases, such as coronary heart diseases, [high blood pressure] and more,” said corresponding study author Guo-Ping Shi of the division of cardiovascular medicine at Brigham and Women’s Hospital in Boston.

“I’ve studied this area for more than 20 years, and the evidence we see from clinical trials, as well as basic research, points to allergic asthma as an important risk factor that clinicians and patients need to be aware of when considering personal risk,” he added.

The review describes clinical studies showing the link between asthma and such health threats as coronary and aortic heart diseases; narrowed arteries that reduce blood flow to the limbs; stroke; heart failure; and other cardiac complications.

The report noted that the build up of specific types of inflammatory cells in the lungs, heart and blood vessels may explain the association between asthma and cardiovascular disease (CVD).

The study, published May 16 in Nature Cardiovascular Research, also outlined clinical studies that examined links between heart disease and seasonal allergies, allergic eczema, and severe food and drug allergies.

“Observations from these studies suggest that allergic reactions besides asthma are also significant risk factors for CVD,” Shi said in a hospital news release.

His team also examined how asthma medications might affect heart disease risk.

Inhaled albuterol (often used to treat acute asthma attacks), inhaled corticosteroids (such as fluticasone propionate and budesonide), and leukotriene modifiers (such as montelukast) appeared to reduce heart disease risk, according to the study.

But oral and intravenous corticosteroids (such as prednisone) appeared to increase the risk. And there were mixed results for anti-asthma antibodies (such as omalizumab), with one study finding increased risk and others showing reduced risk or no effect.

“Based on these previous studies, we can now ask: What is the next direction we need to pursue? What are the weakest points that we can focus on? By connecting work across basic research and clinical studies, we can start to see the bigger picture and think about the implications for patient care,” Shi said.


More information

There’s more on asthma at the American Lung Association.

SOURCE: Brigham and Women’s Hospital, news release, May 17, 2022

What do you think?

25 Comments

Leave a Reply
  1. Does your website have a contact page? I’m having problems locating it but, I’d like to send you an email. I’ve got some suggestions for your blog you might be interested in hearing. Either way, great blog and I look forward to seeing it develop over time.

  2. Good V I should certainly pronounce, impressed with your website. I had no trouble navigating through all tabs as well as related information ended up being truly easy to do to access. I recently found what I hoped for before you know it at all. Reasonably unusual. Is likely to appreciate it for those who add forums or something, site theme . a tones way for your customer to communicate. Nice task..

  3. I?¦ve been exploring for a little for any high-quality articles or weblog posts in this kind of space . Exploring in Yahoo I eventually stumbled upon this site. Reading this information So i am satisfied to show that I have an incredibly good uncanny feeling I found out exactly what I needed. I so much definitely will make certain to do not overlook this web site and provides it a look on a constant basis.

  4. I do enjoy the way you have framed this specific difficulty and it really does offer me personally a lot of fodder for consideration. Nevertheless, coming from what precisely I have observed, I just trust when the reviews stack on that people today continue to be on point and not get started upon a soap box involving some other news du jour. All the same, thank you for this excellent point and though I do not concur with the idea in totality, I value your perspective.

Leave a Reply

Your email address will not be published. Required fields are marked *

Largest Baby Formula Plant in US May Be Able To Reopen by Next Week

Study: Women Calmed With Embrace Of Loved One, Men Not